Glenmark and Ichnos launch Ichnos Glenmark Innovation to accelerate new drug discovery in cancer…
The newly formed IGI features a pipeline of three innovative oncology molecules targeting multiple myeloma, acute myeloid leukemia…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ichnos Sciences
Ichnos Sciences signs licensing pact with Astria Therapeutics for OX40 antagonist monoclonal…
Astria Therapeutics is granted global rights to develop and commercialise OX40 portfolio, comprised of Telazorlimab and its…